Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Forward Pharma A/S (FWP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.55+0.31 (+5.92%)
At close: 03:39PM EDT
Advertisement

Forward Pharma A/S

Oestergade 24A
1st Floor Copenhagen K
Copenhagen 1100
Denmark
45 33 44 42 42
https://www.forward-pharma.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees4

Key Executives

NameTitlePayExercisedYear Born
Mr. Florian Schonharting M.Sc. (Econ)Co-Founder & ChairmanN/AN/A1969
Dr. Claus Bo Søndergaard Svendsen M.D., Ph.D.Chief Exec. OfficerN/AN/A1977
Mr. Thomas CarboneVP of Fin. & ControllerN/AN/A1957
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Corporate Governance

Forward Pharma A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement